Alzheimer's disease Trials in Hornsby, Australia
Conditions / Alzheimer's disease / Hornsby, Australia
Research into Alzheimer's disease spans multiple therapeutic approaches and trial phases.
14 total trials for this combination
Showing top 10 of 14 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00104273 | Rasagiline 1 mg and 2 mg Added to Aricept 10 mg Daily in Patients With Mild to Moderate Alzheimer's Disease (AD) | COMPLETED | PHASE2 |
| NCT01224106 | A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease | COMPLETED | PHASE3 |
| NCT02585934 | Study Evaluating Intepirdine (RVT-101) in Subjects With Mild to Moderate Alzheimer's Disease on Donepezil: MINDSET Study | COMPLETED | PHASE3 |
| NCT02245568 | Open-Label Study of Leuco-methylthioninium Bis(Hydromethanesulfonate) (LMTM) in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD) | TERMINATED | PHASE3 |
| NCT00594568 | Effect of LY450139 on the Long Term Progression of Alzheimer's Disease | COMPLETED | PHASE3 |
| NCT00348140 | Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy In Subjects With Mild To Moderate Alzheimer's Disease | COMPLETED | PHASE3 |
| NCT03114657 | A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD) | TERMINATED | PHASE3 |
| NCT00490568 | Open-Label Extension Study Of Rosiglitazone XR As Adjunctive Therapy In Subjects With Mild-to-Moderate Alzheimers | TERMINATED | PHASE3 |
| NCT01969123 | Study of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease | TERMINATED | PHASE3 |
| NCT02586909 | 12-Month Open-Label Extension Study of Intepirdine (RVT-101) in Subjects With Alzheimer's Disease: MINDSET Extension | TERMINATED | PHASE3 |